Skip to main content
LQDA
NASDAQ Life Sciences

Liquidia Posts $2.64 Loss Per Share for Third Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$50
Mkt Cap
$4.285B
52W Low
$22.31
52W High
$93.61
52W Position info
124% above low
Off High info
47% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $22.31.

Summary

Liquidia reported a third-quarter loss of $2.64 per share, against an IBES estimate of USD 0.96, a swing to red ink after the company posted $74.7M of net income on $170.4M of YUTREPIA sales in Q2 2026. The headline carries no revenue figure, so the size of any top-line miss or beat is not yet clear. The quarter is the first full period since the October settlement with United Therapeutics, under which Liquidia paid $380.7M net to resolve all six lawsuits and preserve YUTREPIA's PAH indication. That cash outlay and the loss together put the balance sheet front and center for a company with a roughly $4.3B market value trading near $50 a share.

At the time of this announcement, LQDA was trading at $50.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $22.31 to $93.61. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Nov 10, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.45
Real-time Price: $48.00 info
Change: +$0.5519 (+1%) info
Market Cap: $4.285B info
LQDA
Nov 10, 2026, 6:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $47.40
Real-time Price: $48.00 info
Change: +$0.600 (+1%) info
Market Cap: $4.285B info
LQDA
Oct 13, 2026, 9:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.50
Real-time Price: $48.00 info
Change: +$8.50 (+22%) info
Market Cap: $4.285B info
LQDA
Oct 13, 2026, 5:50 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $31.76
Real-time Price: $48.00 info
Change: +$16.24 (+51%) info
Market Cap: $4.285B info
LQDA
Oct 02, 2026, 11:47 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $27.77
Real-time Price: $48.00 info
Change: +$20.23 (+73%) info
Market Cap: $4.285B info